International Conference on Tuberculosis ICT on December 09-10, 2024 in New York, United States

Tuberculosis
Medical management of TB
Drug resistance/MDR-TB treatment management
TB in children and LTBI treatment
TB and non-communicable diseases/co-morbidities (non-HIV)
Epidemiology:TB in high-burden countries
Epidemiology:TB in low-burden countries
TB in special populations and institutions (e.g.,migrants,hospitals,prisoners)
TB outbreaks and contact investigations
Expansion and implementation of the Stop TB strategy
Infection control
Public policy
Diabetes and TB

TB Bacteriology and Immunology
Bacteriology
Immunology/pathogenesis
Vaccines/drug development
Clinical trials
TB diagnostics:microscopy
TB diagnostics: culture and rapid detection methods
Drug susceptibility testing for tuberculosis
Zoonotic TB
Quality management systems and quality assurance

Nurses and Allied Professionals
Treatment adherence and case management
Social determinants of health
Education and training (patients and professionals)
Human resource development

Adult and Child Lung Health
Acute respiratory infection
Asthma
Air pollution and occupational lung disease
Pneumonia in adults
Community participation in lung health
Epidemiology
Public policy
Non-communicable diseases

HIV
Diagnostic tools
Treatment and management
HIV-TB programme linkages and integration
Surveillance

Tobacco
Tobacco cessation
Programme implementation
FCTC, MPOWER and tobacco control policies
Advocacy and public education
Tobacco burden and surveillance

Civil Society
Advocacy,human rights,and ethics
Community outreach
Innovative funding
Partnerships